Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Immunome Inc., 3 years.
Immunome Inc.
Director
Swarmer Inc
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immunome Inc. June 9, 202699.8%
-
Immunome Inc. June 7, 202390.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 2026 | Swarmer Inc | In-the-money exercise | +819,487 | $3.33 | $2,731,678 |
| Sep 15, 2026 | Swarmer Inc | Other | −1,124,981 | — | — |
| Mar 23, 2026 | Immunome Inc. | Open-market sale | −28,200 | $20.65 | $582,330 |
| Mar 20, 2026 | Immunome Inc. | Open-market sale | −36,800 | $20.47 | $753,296 |
| Mar 18, 2026 | Swarmer Inc | Derivative conversion | +1,124,981 | — | — |
| Jan 15, 2023 | Immunome Inc. | Grant or award | +8,750 | $4.00 | $35,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.